Zhejiang Taimei Medical Technology begins trading on the HKSE as China's largest digital solution provider for pharma R&D.

Zhejiang Taimei Medical Technology Co., Ltd. has begun trading on the Hong Kong Stock Exchange under the code "2576." As of 2023, it is China's largest digital solution provider for pharmaceutical and medical device R&D, holding a 5.9% market share. The company offers over 40 software products and services to more than 1,400 clients, including many top global pharmaceutical firms. Taimei plans to enhance its offerings and expand its customer base.

October 14, 2024
4 Articles